# China NMPA Drug Inspection - Shijiazhuang Yiling Pharmaceutical Co., Ltd. - Lianhua Qingwen Capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/shijiazhuang-yiling-pharmaceutical-co-ltd/6f2321b8-fec5-41b1-9d20-ed93e3192390/
Source feed: China

> China NMPA drug inspection for Shijiazhuang Yiling Pharmaceutical Co., Ltd. published March 20, 2020. Drug: Lianhua Qingwen Capsules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from Gansu Provincial Drug Administration Regarding Sampling Inspection Information of Drugs Used for COVID-19 Prevention and Control
- Company Name: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-20
- Drug Name: Lianhua Qingwen Capsules
- Inspection Finding: Compliant

Company: https://www.globalkeysolutions.net/companies/shijiazhuang-yiling-pharmaceutical-co-ltd/6246ba30-a2d9-4e15-bb40-70a2335e9de9/